Department of Biomedical Engineering, University of West Attica, Ag. Spyridonos, Egaleo 12243, Greece ...

This Patent Highlight examines three innovative approaches: (1) transmucosal delivery of dephosphorylated psychoactive alkaloids, (2) nonhallucinogenic serotonin receptor modulators, and (3) ergoline ...

Serotonin (5-hydroxytryptamine [5-HT]) receptor subtypes, such as the 5-HT 1A receptor, are considered to mediate the ability of antipsychotic drugs to enhance cognition. On the other hand ...

Under baseline conditions, body weight and food intake may be primarily regulated via the hypothalamic 5-hydroxytryptamine receptor (5-HTR) 2C, whereas following stress the 5-HTR 4 in the medial ...

Selective serotonin reuptake inhibitors, or SSRIs, were the third class or generation of antidepressants developed. They are now the most commonly prescribed antidepressant medications. They are ...

Tryptamine Therapeutics continues its strong end to 2024, reporting positive interim analysis for its phase 2a clinical study ...

The study is assessing the capacity for psilocin – the active metabolite of psilocybin – to bind to serotonin receptors (5HT-2A) in the brain and the gastrointestinal (GI) system, potentially ...

However, the vast majority of the body’s serotonin is produced in the gut, and the serotonin transporter also lines the intestines. “For psychiatric medications that act on receptors in the brain, ...

You can check the lot numbers in the FDA enforcement reports released in October and December. SNRIs vs. SSRIs: Which Work Better? Selective serotonin reuptake inhibitors (SSRIs) and SNRIs are both ...